KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Tax ProvisionsTax Rate
Others
Ratios

BioNTech SE (BNTX) Other Operating Expenses (2023 - 2025)

Historic Other Operating Expenses for BioNTech SE (BNTX) over the last 3 years, with Q3 2025 value amounting to -$1.5 million.

  • BioNTech SE's Other Operating Expenses changed N/A to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year decrease of 91357567.58%. This contributed to the annual value of -$320578.6 for FY2024, which is 10784.08% down from last year.
  • As of Q3 2025, BioNTech SE's Other Operating Expenses stood at -$1.5 million.
  • In the past 5 years, BioNTech SE's Other Operating Expenses registered a high of $3.6 million during Q3 2023, and its lowest value of -$1.5 million during Q3 2025.
  • Moreover, its 3-year median value for Other Operating Expenses was -$105188.4 (2025), whereas its average is $281318.8.
  • Data for BioNTech SE's Other Operating Expenses shows a peak YoY increase of 14965.87% (in 2024) and a maximum YoY decrease of 29778.93% (in 2024) over the last 5 years.
  • Over the past 3 years, BioNTech SE's Other Operating Expenses (Quarter) stood at $215188.0 in 2023, then crashed by 149.66% to -$106859.5 in 2024, then plummeted by 1322.21% to -$1.5 million in 2025.
  • Its Other Operating Expenses stands at -$1.5 million for Q3 2025, versus -$105188.4 for Q1 2025 and -$106859.5 for Q4 2024.